← Open Payments lookup

TRAVIS BAIRD: Open Payments

NPI 1235548314 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,786 in 179 payments from 23 companies in 2025. Trend: 2023 $1,047 · 2024 $2,015 · 2025 $4,786

Food & beverage: $4,153Travel & lodging: $624Education: $9
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc10$860
ABBVIE INC.28$418
Alkermes, Inc.20$392
E.R. Squibb & Sons, L.L.C.12$364
Neurocrine BioSciences, Inc.8$347
Teva Pharmaceuticals USA, Inc.14$267
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$263
Gilead Sciences, Inc.5$260
Lundbeck LLC14$223
Otsuka America Pharmaceutical, Inc.6$222

Products named: SPRAVATO, VRAYLAR, COBENFY, INGREZZA, REXULTI, CAPLYTA, Epclusa, Qelbree.

Industry payments across MD — which companies pay providers there.